This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Non-Medical Drivers of Health Impacting Latino Cancer Health Gaps: Genetic Cancer Risk Assessment
Dr. Alejandra Hurtado de Mendoza is an Assistant Professor at the Cancer Prevention and Control Program at Georgetown Lombardi Comprehensive Cancer Center. Gaps across the continuum Dr. Hurtado de Mendoza’s presentation focused on gaps in genetic cancer risk assessment, multi-level hurdles that Latinos face across the genetic cancer risk assessment continuum, and an example of a multilevel intervention to decrease gaps. The presentation began by discussing how gaps in the genetic cancer risk assessment continuum begin with awareness. Only 23% of Latino individuals were aware of ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Latino Cancer Survivors’ Quality of Life and Survivorship Care
Dr. Kristi D. Graves is a tenured Professor of Oncology, Cancer Prevention and Control Program leader at the Lombardi Comprehensive Cancer Center, and Associate Dean for Faculty Development at Georgetown University Medical Center. Latino cancer survivorship Dr. Graves’s presentation began by discussing cancer survivorship across the cancer continuum. The National Cancer Institute’s (NCI) Office of Cancer Survivorship states that “an individual is considered a cancer survivor from the time of diagnosis through the balance of life. There are many types of survivors, including those living with cancer and those ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Adapting NCI’s Clinical Trials System to a Changed Clinical Research Environment
Dr. James H. Doroshow is Deputy Director for Clinical and Translational Research at the National Cancer Institute (NCI). This plenary session occurred at 8:30 am., Thursday, Feb. 22, 2024, at the 4th biennial Advancing the Science of Cancer in Latinos conference. COVID’s impact on cancer clinical trials Dr. Doroshow’s presentation began by discussing the initial and continuing effects of the pandemic environment on cancer clinical trials. From the start of the pandemic, several aspects of clinical trials were altered, including informed consent and in-person study activities. One major ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Advances in Evidence-based Digital Solutions for Supporting Latino Cancer Patients
Dr. John Piette is Professor in the School of Public Health, and Director of the Center for Managing Chronic Disease (CMCD) at the University of Michigan. Cognitive behavioral therapy Dr. Piette’s presentation began by discussing how cognitive behavioral therapy (CBT) can be used for Latino cancer patients. CBT is the most common evidence-based intervention for cancer patients struggling with mental health, symptoms, stress, and sleep. In cancer patients, CBT has been shown to help manage distress and pain, alleviate insomnia, manage fear of cancer recurrence, and reduce emotional distress and ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
The NCI Community Oncology Research Program: Opportunities to Increase Latino Participation in Clinical Trials
Dr. Brenda Adjei is Associate Director of the HDRP at the National Cancer Institute (NCI) Center for Cancer Research. The NCI Community Oncology Research Program Dr. Adjei’s presentation began with a discussion of Latino participation in cancer clinical trials. Variety in clinical trials is critically important because it generates biomedical knowledge relevant to all, builds trust and trustworthiness, and contributes to reductions in health gaps and fair research participation. Current limits in clinical research is due to multilevel hurdles and requires tailored, ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Conclusion
To eliminate gaps in cancer care in Latino populations, Advancing the Science of Cancer in Latinos brought together researchers, scientists, physicians, healthcare professionals, patient navigators, and students from across the US and Latin America. These presenters shared research advancements, identified gaps, developed actionable goals, updated clinical best practices, described effective community interventions, and detailed professional training programs aimed at addressing inequity. In the process, most of the speakers made recommendations, either specific to their field of study or more broadly. The following are some key recommendations abstracted from their conference ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Healthcare Gaps in the Latino Community
The Latino population both within and outside the US has significant heterogeneity. [Velazquez-Villarreal] After all, Latin America has been a melting pot of mixed populations for 500 years, with over 20 heritage groups recognized by the Hispanic Community Health Study/Study of Latinos. These groups are distinct, with unique backgrounds, language, and US influence, but are also connected by more similarities than differences. [Perez-Stable] Latino individuals are the largest and youngest overlooked community in the US and are projected to account for more than half of the overall growth through 2060. Compared to non-Hispanic White individuals, ...
Over the last several years, cities across the US have taxed sugary drinks to reduce the consumption of these beverages and prioritize the health of their communities. In 2018, Seattle joined this wave of cities in placing a tax on sugary drinks. At 1.75 cents per ounce, the tax was created to disincentivize the consumption and purchase of sugary drinks and improve community health. But did it work? A recent study published on the JAMA Network sought to answer this very question by comparing the health of children within the taxable area to those in neighboring areas. This is what they found.
Sugary Drink Tax Studies
Studying the relationship between the sugary drink tax and health is nothing new. In fact, previous studies on taxes have pointed to a ...
One in four U.S. adults were living with a mental health condition as of last year — that’s nearly 60 million people, according to the Substance Abuse and Mental Health Services Administration. Many questions remain about the rise of mental health issues. That's why the National Institutes of Health’s All of Us Research Program has taken a special interest in mental health. As part of the program’s mission to collect the health data of over 1 million Americans, the All of Us Research Program is learning more about the mental health backgrounds of participants, which could advance mental health research. When signing up for the program, participants fill out mental health surveys. Through these surveys researchers can study early mental illness risk ...
